Company insight Reimagine the
s one of the world’s most heavily regulated industries, the pharma industry overall has been slow to adapt to industry 4.0. Audit trails span numerous validation systems and incorporate webs of ISO standards, SOPs and GxP requirements, and the regulatory environment differs from country to country, making it more complicated to digitalise on a global scale. In this environment, real-time visibility is a crucial capability for agile pharma supply chains. While data is still key, knowledge doesn’t help anyone if it can’t be acted upon in a timely manner. IoT technology and predictive analytics enable pharmaceutical companies today to use the ever-growing amount of data to make decisions instantly and to act immediately or even automatically.
A The stakes are high
The pharma industry is heavily regulated for good reason, with products that can literally be a matter of life or death. Quality is paramount. This is also why data integrity is critical and digitalisation of the pharmaceutical industry is so important. This is a game changer for world health outcomes.
Looking at global vaccine distribution alone, prior to 2020 an estimated 25– 50% of vaccines were wasted each year due to broken cold chains. The intense pressure on the sector since 2020 has shone a spotlight on the industry front runners who are relatively ahead in digitalisation. For those monitoring their supply chain with real-time visibility, Covid vaccine producers have achieved success rates close to 100%.
Digitalisation is the way forward The huge saving in waste is reason enough for pharmaceutical and supply
pharma supply chain
Using digital platforms to transform pharma supply chains, companies are reaping significant benefits in terms of efficiency, quality, sustainability, scalability and payback. Controlant is at the forefront of this transformation, working at scale with large pharma companies.
Controlant’s IoT device-enabled platform helps customers achieve an annualised return on investment.
chain leaders to invest heavily in digital transformation, and there are many other significant benefits. Being certain of data integrity in real time makes it easier to build flexibility into stability budgets, for example, and helps prevent counterfeit and other fraudulent activities.
Company insight
Controlant provides pharmaceutical companies with real-time visibility and valuable insights that make their supply chains more agile and resilient from end to end. With Controlant’s IoT device-enabled platform, customers
“Stakeholders can act on information in real time to ensure quality, mitigate any negative impact, and prevent waste.”
A lack of visibility disrupts time to market and makes it impossible to optimise stock levels or production rates, and fragmented data lengthens release times. Digitalisation is our best weapon against these costly challenges. End- to-end, real-time visibility can only be achieved with highly digitalised, automated processes. By leveraging real-time data, held on a single platform, pharma chiefs gain the ability to overcome some of the industry’s most adverse challenges.
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
are achieving an annualised return on investment and millions in savings, reducing material losses, enhancing the reliability and sustainability of their operations, and gaining peace of mind. Stakeholders can act in real time to ensure consistently high quality, mitigate any negative impact and prevent waste. Services include 24/7 monitoring and IoT device management, including reverse logistics. ●
www.controlant.com 27
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53
